238 related articles for article (PubMed ID: 17710674)
21. Elevated serum α-fetoprotein levels in patients with chronic hepatitis C virus genotype 4: not the end of the story.
Abdel-Razik A; Mousa N; Abdel-Aziz M; Elhelaly R; Elzehery R; Zalata K; Elkashef W; Fouda O; Awad M; Hafez M; Eldars W
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):313-22. PubMed ID: 26618566
[TBL] [Abstract][Full Text] [Related]
22. Polaprezinc attenuates cyclophosphamide-induced cystitis and related bladder pain in mice.
Murakami-Nakayama M; Tsubota M; Hiruma S; Sekiguchi F; Matsuyama K; Kimura T; Moriyama M; Kawabata A
J Pharmacol Sci; 2015 Feb; 127(2):223-8. PubMed ID: 25727961
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C.
Esmat G; Metwally M; Zalata KR; Gadalla S; Abdel-Hamid M; Abouzied A; Shaheen AA; El-Raziky M; Khatab H; El-Kafrawy S; Mikhail N; Magder LS; Afdhal NH; Strickland GT
J Hepatol; 2007 Apr; 46(4):620-7. PubMed ID: 17316875
[TBL] [Abstract][Full Text] [Related]
24. Effects of polaprezinc on morphological change of the tongue in zinc-deficient rats.
Kinomoto T; Sawada M; Ohnishi Y; Yamaguchi T; Tsuge S; Ogawa S; Washizuka M; Minaguchi J; Mera Y; Takehana K
J Oral Pathol Med; 2010 Sep; 39(8):617-23. PubMed ID: 21054547
[TBL] [Abstract][Full Text] [Related]
25. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
[TBL] [Abstract][Full Text] [Related]
26. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K
J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
[TBL] [Abstract][Full Text] [Related]
27. Tissue distribution of polaprezinc in rats determined by the double tracer method.
Furuta S; Suzuki M; Toyama S; Miwa M; Sano H
J Pharm Biomed Anal; 1999 Mar; 19(3-4):453-61. PubMed ID: 10704111
[TBL] [Abstract][Full Text] [Related]
28. Polaprezinc (Zinc-L-Carnosine Complex) as an Add-on Therapy for Binge Eating Disorder and Bulimia Nervosa, and the Possible Involvement of Zinc Deficiency in These Conditions: A Pilot Study.
Sakae K; Suka M; Yanagisawa H
J Clin Psychopharmacol; 2020; 40(6):599-606. PubMed ID: 33044355
[TBL] [Abstract][Full Text] [Related]
29. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].
Kim SM; Sohn JH; Kim TY; Roh YW; Eun CS; Jeon YC; Han DS; Oh YH
Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264
[TBL] [Abstract][Full Text] [Related]
30. Residence time of polaprezinc (zinc L-carnosine complex) in the rat stomach and adhesiveness to ulcerous sites.
Furuta S; Toyama S; Miwa M; Itabashi T; Sano H; Yoneta T
Jpn J Pharmacol; 1995 Apr; 67(4):271-8. PubMed ID: 7650862
[TBL] [Abstract][Full Text] [Related]
31. Changes in tissue contents of zinc, copper and iron in rats and beagle dogs treated with polaprezinc.
Yamaguchi I; Shibata K; Takei M; Matsuda K
J Toxicol Sci; 1996 Aug; 21(3):177-87. PubMed ID: 8887886
[TBL] [Abstract][Full Text] [Related]
32. Effect of blood letting on serum aminotransferase levels of patients with chronic hepatitis C and iron overload.
Girelli CM; Mirata C; Casiraghi A
Recenti Prog Med; 1998 May; 89(5):241-4. PubMed ID: 9676130
[TBL] [Abstract][Full Text] [Related]
33. Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection.
Giannini E; Botta F; Borro P; Malfatti F; Fumagalli A; Testa E; Podestà E; Chiarbonello B; Polegato S; Mamone M; Testa R
Am J Gastroenterol; 2003 Nov; 98(11):2516-20. PubMed ID: 14638357
[TBL] [Abstract][Full Text] [Related]
34. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
[TBL] [Abstract][Full Text] [Related]
35. Disposition of polaprezinc (zinc L-carnosine complex) in rat gastrointestinal tract and effect of cimetidine on its adhesion to gastric tissues.
Furuta S; Toyama S; Miwa M; Sano H
J Pharm Pharmacol; 1995 Aug; 47(8):632-6. PubMed ID: 8583362
[TBL] [Abstract][Full Text] [Related]
36. The ratio of insulin-like growth factor-I/insulin-like growth factor-binding protein-3 in sera of patients with hepatitis C virus-related chronic liver disease as a predictive marker of insulin resistance.
Himoto T; Tani J; Miyoshi H; Yoneyama H; Mori H; Inukai M; Masugata H; Goda F; Senda S; Haba R; Masaki T
Nutr Res; 2013 Jan; 33(1):27-33. PubMed ID: 23351407
[TBL] [Abstract][Full Text] [Related]
37. Association of genetic polymorphism -670A>G in the Fas gene and serum markers AST platelet ratio index, AST/ALT with significant fibrosis and cirrhosis in chronic hepatitis C.
Deghady A; Abdou A; El-Neanaey WA; Diab I
Genet Test Mol Biomarkers; 2012 Jun; 16(6):531-5. PubMed ID: 22352690
[TBL] [Abstract][Full Text] [Related]
38. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and Safety of Polaprezinc (Zinc Compound) on Zinc Deficiency: A Systematic Review and Dose-Response Meta-Analysis of Randomized Clinical Trials Using Individual Patient Data.
Furihata K; Tsuchikawa M; Miwa T; Naito Y; Oba K; Sakagami M
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32316581
[TBL] [Abstract][Full Text] [Related]
40. Randomized controlled trial of consensus interferon with or without zinc for chronic hepatitis C patients with genotype 2.
Suzuki H; Sato K; Takagi H; Kanda D; Sohara N; Kakizaki S; Nakajima H; Otsuka T; Nagamine T; Mori M
World J Gastroenterol; 2006 Feb; 12(6):945-50. PubMed ID: 16521225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
